Possibilities and prospects for glucocorticoid withdrawal in systemic lupus erythematosus
The efficiency of glucocorticoid (GC) therapy for systemic lupus erythematosus (SLE) is beyond question and is confirmed by the experience gained over many decades of their use. However, there are many problems with prolonged GC use, even in its low and medium doses. In particular, the development o...
Saved in:
| Main Authors: | S. K. Solovyev, E. A. Aseeva, E. L. Nasonov, A. M. Lila, G. M. Koilubaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2020-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/986 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucocorticoid toxicity index in patients with systemic lupus erythematosus (preliminary data)
by: E. V. Ermolaeva, et al.
Published: (2024-02-01) -
Objective assessment of the damaging effect of glucocorticoids (toxicity index) in patients with systemic lupus erythematosus
by: N. Yu. Nikishina, et al.
Published: (2021-12-01) -
GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS
by: T. M. Reshetnyak, et al.
Published: (2014-07-01) -
Clinical manifestations, courses, and outcomes of systemic lupus erythematosus in the dwellers of Kyrgyzstan
by: G. M. Koilubaeva, et al.
Published: (2016-10-01) -
Data from a prospective study of the features of systemic lupus erythematosus in patients of Kyrgyzstan (Eurasian RENAISSANCE Register)
by: G. M. Koilubaeva, et al.
Published: (2020-03-01)